Skip to content

Opening book details…

About this Medicine article

P-113 FIGHT-302: Phase 3 study of first-line pemigatinib vs gemcitabine + cisplatin for cholangiocarcinoma with FGFR2 fusions or rearrangement by Bekaii-Saab, T. (author);Valle, J. (author);Van Cutsem, E. (author);Rimassa, L. (author);Furuse, J. (author);Ioka, T. (author);Macarulla, T. (author);Bridgewater, J. (author);Wasan, H. (author);Borad, M. (author);Vogel, A. (author);Lihou, C. (author);Zhen, H. (author);Jiang, P. (author);Langmuir, P. (author);Melisi, D. (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Bekaii-Saab, T. (author);Valle, J. (author);Van Cutsem, E. (author);Rimassa, L. (author);Furuse, J. (author);Ioka, T. (author);Macarulla, T. (author);Bridgewater, J. (author);Wasan, H. (author);Borad, M. (author);Vogel, A. (author);Lihou, C. (author);Zhen, H. (author);Jiang, P. (author);Langmuir, P. (author);Melisi, D. (author)
Publisher
Elsevier BV
Published
2021
Field
Medicine (Health Sciences)

More by Bekaii-Saab, T. (author);Valle, J. (author);Van Cutsem, E. (author);Rimassa, L. (author);Furuse, J. (author);Ioka, T. (author);Macarulla, T. (author);Bridgewater, J. (author);Wasan, H. (author);Borad, M. (author);Vogel, A. (author);Lihou, C. (author);Zhen, H. (author);Jiang, P. (author);Langmuir, P. (author);Melisi, D. (author)

Browse all works by Bekaii-Saab, T. (author);Valle, J. (author);Van Cutsem, E. (author);Rimassa, L. (author);Furuse, J. (author);Ioka, T. (author);Macarulla, T. (author);Bridgewater, J. (author);Wasan, H. (author);Borad, M. (author);Vogel, A. (author);Lihou, C. (author);Zhen, H. (author);Jiang, P. (author);Langmuir, P. (author);Melisi, D. (author)